Cancer News and Research

Latest Cancer News and Research

Study finds that cancer cells may be susceptible to metabolic stress

Research at the University of Adelaide has discovered cancer cells may be particularly susceptible to metabolic stress - opening the way for new targeted therapy that won't harm normal cells.

3 Dec 2014

Myriad Genetics to highlight clinical data from three Prolaris studies at SUO 2014

Myriad Genetics, Inc. today announced that clinical data from three studies with Prolaris in prostate cancer patients will be highlighted at the 2014 Society of Urologic Oncology Annual Meeting being held tomorrow in Rockville, Md. The new data show that the Prolaris test could save the healthcare system $6 billion over 10 years and that physicians are using the test appropriately to personalize treatment options for their patients.

3 Dec 2014

Abnormal activation of cell death pathways may lead to inflammatory skin diseases

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways of treating these diseases.

3 Dec 2014

University of Chicago collaborates with NCI to set up Genomic Data Commons

The University of Chicago is collaborating with the National Cancer Institute to establish the nation's most comprehensive computational facility that stores and harmonizes cancer genomic data generated through NCI-funded research programs.

3 Dec 2014

UNM Cancer Center program to help new scientists learn nuances of conducting science

create a set of systems to track people, projects and money. But scientists' formal training doesn't always include business classes. To bridge this gap, Michelle Ozbun, PhD, at the University of New Mexico Cancer Center, is improving a program that helps new scientists learn nuances of conducting science.

3 Dec 2014

Researchers find way to prevent noise-induced hearing loss

Researchers from Weill Cornell Medical College and the Gladstone Institutes have found a way to prevent noise-induced hearing loss in a mouse using a simple chemical compound that is a precursor to vitamin B3. This discovery has important implications not only for preventing hearing loss, but also potentially for treating some aging-related conditions that are linked to the same protein.

3 Dec 2014

Researchers find link between vitamin D deficiency and seasonal affective disorder

Vitamin D deficiency is not just harmful to physical health--it also might impact mental health, according to a team of researchers that has found a link between seasonal affective disorder, or SAD, and a lack of sunlight.

3 Dec 2014

Maternal age and successful egg freezing with PGS: an interview with Dr. Santiago Munné

The leading cause of of pregnancy loss or infertility is chromosomal abnormality or imbalance, where extra genetic material is present or some is missing - what’s called aneuploidy. This imbalance leads to the inability to produce viable embryos or pregnancy.

2 Dec 2014

Monash University, 60P Australia partner to develop Fenretinide drug for dengue fever

Monash University and 60P Australia Pty Ltd, a subsidiary of 60° Pharmaceuticals LLC, have announced today an exclusive partnering deal, with 60P obtaining rights to develop the drug Fenretinide for dengue fever.

2 Dec 2014

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Advion, Inc. announces that is its TriVersa NanoMate with liquid extraction surface analysis (LESA) capability will be evaluated as part of a study at Brigham and Women’s Hospital.

From Advion 2 Dec 2014

Oncolytics Biotech submits Orphan Drug Designation for pancreatic, ovarian cancers

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted applications for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.

2 Dec 2014

Researchers identify possible prognostic biomarker in triple-negative breast cancer

"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-).

2 Dec 2014

Apellis Pharmaceuticals completes $33M private placement of Series C Preferred Stock

Apellis Pharmaceuticals, Inc., a leading biotechnology company applying immunotherapy to autoimmune disease, today announced that it has completed a $33M private placement of its Series C Preferred Stock.

2 Dec 2014

Mercy Medical Center partners with Everseat to employ new scheduling platform for Women's Services

Mercy Medical Center has announced that it has entered into an agreement with Everseat to employ an all new mobile scheduling platform for its Women's Services, including: Gynecology, Gynecologic Oncology, Breast Disease and Breast Cancer, Imaging Services such as mammograms, and Endocrinology, including diabetes, thyroid and bone health.

2 Dec 2014

Faster and more accurate method for testing new cancer drugs

Finding faster and more accurate ways to test new cancer drugs is always a priority for cancer researchers.

2 Dec 2014

Antacid medicines improve overall survival in patients with head and neck cancer

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study from the University of Michigan Comprehensive Cancer Center.

2 Dec 2014

Children with change in SUFU gene more likely to develop brain tumour

Gorlin syndrome causes an increased risk of developing cancers of the skin and, rarely, in the brain. Around 1 in 30,000 people has the condition.

From The University of Manchester 2 Dec 2014

BioMed Central plans to publish new journal Research Involvement and Engagement

The open access publisher BioMed Central is pleased to announce its plans to publish the new innovative journal Research Involvement and Engagement, which aims to publish its first articles in June 2015.

2 Dec 2014

Global stem cell market estimated to reach US$117.66B in 2018

Stem cells have the potential to transform healthcare by enabling the cost-effective treatment of many conditions that currently have poor treatment options.

2 Dec 2014

Novartis to highlight advances in blood, breast cancer research at ASH and SABCS 2014

Novartis will highlight more than 250 abstracts demonstrating advances in blood and breast cancer research at the upcoming American Society of Hematology (ASH) annual meeting December 6-9, and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) December 9-13.

2 Dec 2014

Cancer News and Research

Latest Cancer News and Research

Study finds that cancer cells may be susceptible to metabolic stress

Myriad Genetics to highlight clinical data from three Prolaris studies at SUO 2014

Abnormal activation of cell death pathways may lead to inflammatory skin diseases

University of Chicago collaborates with NCI to set up Genomic Data Commons

UNM Cancer Center program to help new scientists learn nuances of conducting science

Researchers find way to prevent noise-induced hearing loss

Researchers find link between vitamin D deficiency and seasonal affective disorder

Maternal age and successful egg freezing with PGS: an interview with Dr. Santiago Munné

Monash University, 60P Australia partner to develop Fenretinide drug for dengue fever

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Oncolytics Biotech submits Orphan Drug Designation for pancreatic, ovarian cancers

Researchers identify possible prognostic biomarker in triple-negative breast cancer

Apellis Pharmaceuticals completes $33M private placement of Series C Preferred Stock

Mercy Medical Center partners with Everseat to employ new scheduling platform for Women's Services

Faster and more accurate method for testing new cancer drugs

Antacid medicines improve overall survival in patients with head and neck cancer

Children with change in SUFU gene more likely to develop brain tumour

BioMed Central plans to publish new journal Research Involvement and Engagement

Global stem cell market estimated to reach US$117.66B in 2018

Novartis to highlight advances in blood, breast cancer research at ASH and SABCS 2014

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in